R. Haubner, E. Rauchenwald, M. Lessiak, R. Pitonak and R. Weissenbacher
, R., Köpf, A., Weissenbacher, R.: Physica Status Solidi C, vol. 12, 2015, p. 1043
 Bonetti-Lang, M., Bonetti, R., Hintermann, HE. In: Proc 8 th Int Conf on CVD, 1981, p. 606
 Rauchenwald, E., Lessiak, M., Weissenbacher, R., Haubner, R.: (to be published).
 Osada, A., Danzinger, M., Haubner, R., Lux, B.: Journal de Physique IV, Coll.C2, vol. 1, 1991, p. 557
 Iiyoshi, H.: Doctoral Thesis. Vienna : TU, 1990
 Altena, H., Lux, B.: Int. J. Refract. Met. Hard Mater., vol. 6, 1987, p. 53
 Peng, J., Danzinger, M
Reda Abdelbaset, Mohamed El Dosoky and Mohamed T. El-Wakad
rate measuring using bioimpedance technique will be a new addition in medical devices unlike existing devices due to the already mentioned advantages [ 2 ].
A rated 17.5 million people died from cardiovascular disease (CVDs) in 2012, representing 31% of all global deaths. However, people who suffer from CVDs because of the existence of one or more risk reasons such as hypertension and diabetes, need early detection [ 3 ].
The electrical properties of biological tissues are divided into two categories corresponding to the source of the electrical signal, active
At present, one of the major reasons of death in the world is cardiovascular disease (CVD), related to the epidemiological transition of unhealthy lifestyles such as smoking habits, diabetes mellitus and obesity [ 1 , 2 ]. Atrial and ventricular arrhythmias are two important factors in cardiovascular disease of which cardiac rhythm disorder and heartbeat abnormalities are great public challenges in developed countries. It can be said that the variations in the heart cellular electrophysiology are the main cause for arrhythmias, as common causes
device (“Cerberus”) was developed and tested for use in the study [ 35 , 36 , 37 , 38 ].
The objectives of the study were as follows: (1) to collect and compare the prevalence of known CVD and stroke risk factors in a specific population in order to identify individuals at high risk for cardiovascular disease (CVD) generally and specifically for stroke; 2) to validate REG measurements obtained with an experimental screening device (“Cerberus”); 3) to compare the results of REG measurements with results obtained using Doppler ultrasound; (4) to compare the survey